Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248857 · ClinicalTrials.gov registry record · NA
Promoting the Universal Medication Schedule Via Mobile and EHR Technologies
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 452
- Enrollment target
NCT02248857 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 452 participants.
The verdict
NCT02248857, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
Study Summary
The purpose of this study test the effectiveness of the Universal Medication Schedule (UMS), which was designed as a strategy to standardize and simplify medication instructions to support safe and effective prescription drug use among diabetic.
Interventions
- OTHER UMS Strategy
- OTHER SMS Texting Reminders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02248857
The ClinicalTrials.gov registry entry for NCT02248857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which UMS Strategy is the first listed.
NCT02248857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02248857 about?
NCT02248857 is a clinical study titled "Promoting the Universal Medication Schedule Via Mobile and EHR Technologies". The purpose of this study test the effectiveness of the Universal Medication Schedule (UMS), which was designed as a strategy to standardize and simplify medication instructions to support safe and effective prescription drug use among diabetic.
What is the current status of trial NCT02248857?
This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2014-12. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02248857?
The interventions under investigation include: UMS Strategy (OTHER), SMS Texting Reminders (OTHER).
Who is sponsoring clinical trial NCT02248857?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.